Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

PKC412 in Patients With Acute Myeloid Leukemia and Patients With Myelodysplastic Syndrome With Either Wild Type or Mutated FLT3

This study has been completed.
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
University of California, Los Angeles
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT00045942
First received: September 16, 2002
Last updated: February 19, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2003
  Primary Completion Date: September 2003 (Final data collection date for primary outcome measure)